Travere Therapeutics (TVTX) Non Operating Income (2012 - 2026)
Travere Therapeutics (TVTX) reported Non Operating Income of $1.17 million for Q3 2026, up 49.8% from $783,000 a year earlier.
Powered by 
Analysis
Travere Therapeutics (TVTX) Non Operating Income (2012 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Travere Therapeutics' Non Operating Income came in at -$26.23 million; for FY2025, it came in at $13.55 million, up 308.5% from FY2024.
- By year, Non Operating Income came in at $3.32 million in FY2024 (-72.4%), $12.03 million in FY2023, -$11.34 million in FY2022 and -$17.46 million in FY2021.
- Five-year quarterly Non Operating Income spans a low of -$38.96 million in Q2 2026 and a high of $11.36 million in Q4 2025.
- Year over year, Non Operating Income gained in 1 of the last five quarters, with an average decline of 45.6%.
- The high point for year-over-year Non Operating Income in five years was Q4 2023 (growth of 405.3%); the low point was Q4 2024 (a decline of 93.0%).
- Per Business Quant data, the three quarters before Q3 2026 came in at -$38.96 million (Q2 2026), $193,000 (Q1 2026) and $11.36 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | 1.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.17 Mn |
| Jun 30, 2026 | -38.96 Mn |
| Mar 31, 2026 | 193,000.00 |
| Dec 31, 2025 | 11.36 Mn |
| Sep 30, 2025 | 783,000.00 |
| Jun 30, 2025 | -85,000.00 |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 397,000.00 |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | -1.86 Mn |
| Mar 31, 2024 | 3.47 Mn |
| Dec 31, 2023 | 5.71 Mn |
| Sep 30, 2023 | 3.36 Mn |
| Jun 30, 2023 | 2.08 Mn |
| Mar 31, 2023 | 883,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | -1.31 Mn |
| Jun 30, 2022 | -1.53 Mn |
| Mar 31, 2022 | -9.79 Mn |
| Dec 31, 2021 | -3.92 Mn |
API Access
Travere Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();